Related Experiment Video
Updated: Jul 13, 2026

Human Internal Mammary Artery IMA Transplantation and Stenting: A Human Model to Study the Development of In-Stent Restenosis
Published on: May 9, 2012
Bilateral versus unilateral internal mammary revascularization in patients with diabetes
Masahiro Endo1, Yasuko Tomizawa, Hiroshi Nishida
1Department of Cardiovascular Surgery, The Heart Institute of Japan, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, Japan. Endo@hij.twmu.ac.jp
Insights
Bilateral internal mammary artery (BIMA) grafts improve graft patency and long-term survival in diabetic patients undergoing coronary artery bypass grafting (CABG) with preserved ejection fraction. However, reduced ejection fraction limits the survival benefit of BIMA grafts.
Area of Science:
- Cardiovascular Surgery
- Diabetology
- Thoracic Surgery
Background:
- Coronary artery bypass grafting (CABG) is a common procedure for multivessel disease.
- The use of internal mammary artery (IMA) grafts is standard practice.
- The benefit of bilateral IMA (BIMA) grafts in diabetic patients remains a subject of investigation.
Purpose of the Study:
- To evaluate the efficacy of BIMA grafts compared to single IMA (SIMA) grafts in diabetic patients undergoing CABG.
- To assess early and long-term outcomes, including graft patency and survival rates.
- To determine if ejection fraction influences the benefit of BIMA grafts.
Main Methods:
- Historical cohort study of 1131 patients undergoing isolated, primary, multiple CABG with skeletonized IMA grafts.
- Comparison between diabetic patients receiving SIMA (n=277) and BIMA (n=190) grafts.
- Median follow-up of 8.1 years, analyzing graft patency, hospital mortality, and long-term survival.
Main Results:
- Early graft patency was significantly higher with BIMA (97.7%) versus SIMA (93.8%).
- No significant difference in overall survival rates between SIMA and BIMA groups.
- In patients with preserved ejection fraction, BIMA use was associated with significantly higher 10-year survival and improved freedom from adverse cardiac events.
Conclusions:
- Skeletonized BIMA grafts offer significant benefits in coronary revascularization for diabetic patients with preserved ejection fraction.
- The survival benefit of BIMA grafts is limited in diabetic patients with reduced ejection fraction due to higher cardiac mortality.
- BIMA grafting should be considered in selected diabetic patients to improve long-term outcomes.
Background:
This historical cohort study evaluated the benefit of bilateral internal mammary artery (BIMA) grafts in coronary bypass grafting (CABG) for patients with diabetes.
Methods And Results:
We performed elective, isolated, primary, multiple CABG using skeletonized internal mammary artery (IMA) grafts for multivessel disease in 1131 patients, 467 (41.3%) of whom had type 2 diabetes mellitus. The early and long-term results were compared between 277 patients with diabetes using single IMA (SIMA) grafts and 190 using BIMA grafts (median follow-up, 8.1 years). Hospital mortality was similar in both groups. Early patency rate of all grafts was significantly higher using BIMA than using SIMA (97.7% versus 93.8%, P=0.0012). Survival rates were not significantly different between SIMA and BIMA groups. Late cardiac mortality was significantly higher in patients with low ejection fraction (0.4 or lower) compared with preserved ejection fraction (higher than 0.4) (P=0.0001). In patients with preserved ejection fraction, 10-year survival rate was significantly higher using BIMA than using SIMA (87.8+/-3.5% versus 75.2+/-3.4%, P=0.04), and 10-year all death-free or repeat CABG or recurrent myocardial infarction-free rate was significantly higher using BIMA than using SIMA (86.6+/-3.6% versus 69.0+/-3.7%, P=0.0086). The hazard ratio for all death or repeated CABG or recurrent myocardial infarction in patients with preserved ejection fraction was markedly lower in the BIMA group (0.53; 95% CI, 0.31 to 0.9; P=0.019).
Conclusions:
Skeletonized BIMA grafts are beneficial in coronary revascularization for diabetic patients with preserved ejection fraction but have limited survival benefit for those with reduced ejection fraction attributable to high cardiac mortality.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Complications of Diabetes Mellitus

